Fapon Biotech

Fapon Biotech is a global leader in the in vitro diagnostics industry with over two decades of experience. The company supplies more than 1,400 types of antigens, antibodies, enzymes and other raw materials to over 2,500 customers worldwide across more than 70 countries. Its open-system instrument platforms support chemiluminescence immunoassays (CLIA), molecular point-of-care testing (POCT), fluorescence immunochromatography and high-throughput gene sequencing. Recent clinical validation studies highlight the effectiveness of its PSP CLIA reagent solution for early sepsis detection in China; this test leverages exclusive rights to the PSP biomarker through partnerships with Abionic SA and LASCCO SA. The company’s reagents played a significant role during the COVID‑19 pandemic by enabling rapid test kit development globally.[1][2][3][5][8]